In drug discovery, targeted protein degradation is a method that selectively eliminates disease-causing proteins. A ...

A team of scientists has used a novel approach to identify protein degraders that target Pin1, a protein involved in pancreatic cancer development. In drug discovery, targeted protein degradation is a ...

University of California, Riverside scientists have designed novel agents that bind to and degrade Pin1, a protein linked to ...

Biopharma developer Kesmalea appoints Robert Johnson as CEO to lead development of pipeline focused on oral, CNS penetrant ...

EpiBiologics, a leader in tissue-selective extracellular protein degradation, will be presenting new data demonstrating the unique capabilities of its EpiTAC platform at the 16th Annual PEGS Europe ...

KinCon biolabs, a spin-off from the University of Innsbruck, is expanding its patented platform technology to support ...

KinCon biolabs now uses its technology to predict and this in living cells, whether drug candidates effectively bind to ...

Graduate student Dina Rogers won the prestigious Falling Walls global competition in Berlin, Germany last week for her pitch ...

In a report released today, Andrew Fein from H.C. Wainwright maintained a Buy rating on Kymera Therapeutics (KYMR – Research Report), ...